Clinical Trials Sponsored by Triangle Biostatistics

Total 127 results

Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates; Triangle Biostatistics

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis

Primary Biliary Cholangitis

United States, Spain, Canada, Australia, United Kingdom, Germany, Netherlands, Belgium, Austria, France
Enanta Pharmaceuticals, Inc
ICON Clinical Research; Triangle Biostatistics

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Non-Alcoholic Steatohepatitis

Non-Alcoholic Steatohepatitis

United States, United Kingdom, New Zealand, Canada, France, Puerto Rico
Triangle Pharmaceuticals

Unknown

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

Hepatitis B

United States, Canada, China, France, Singapore
Bristol-Myers Squibb
Boehringer Ingelheim; Triangle Pharmaceuticals

Terminated

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

HIV Infections

United States
Kringle Pharma, Inc.

Recruiting

Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury

Acute Spinal Cord Injury

Japan
Abbott
Group Data Management Biostatistics

Completed

Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs

Rheumatoid Arthritis | Psoriatic Arthritis | Ankylosing Spondylitis

Austria
Kringle Pharma Europe AB
Kringle Pharma, Inc.

Unknown

Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers

Chronic Venous Leg Ulcers

Norway, Sweden
Universidade Federal do Triangulo Mineiro

Recruiting

Integrative and Complementary Health Practices (PICS) (PICS)

Neoplasms | Epilepsy

Brazil
Triangle Pharmaceuticals

Completed

A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive

HIV Infections

United States
Triangle Pharmaceuticals

Completed

A Study of MKC-442 in Combination With Other Anti-HIV Drugs

HIV Infections

United States
Triangle Pharmaceuticals

Suspended

A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

HIV Infections

United States
Triangle Pharmaceuticals

Completed

Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination

HIV Infections

United States
Triangle Pharmaceuticals

Completed

A Study of MKC-442 in HIV-Positive Patients

HIV Infections
Kringle Pharma, Inc.

Recruiting

Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar

Vocal Fold Scar

Japan
Kringle Pharma, Inc.

Completed

Phase I/II Study of KP-100IT in Acute Spinal Cord Injury

Spinal Cord Injuries

Japan
Nantes University Hospital
CSAPA Apsyades; OPPELIA-Le triangle

Completed

Treatment for Opiate Addiction: Prognostic fActors of Responsiveness to Maintenance Treatment (TOPAZE)

Opioid-use Disorder

France
Bristol-Myers Squibb
Triangle Pharmaceuticals; Pharmacia and Upjohn

Terminated

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

HIV Infections

United States
Triangle Pharmaceuticals

Unknown

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

HIV Infections

United States, Argentina, Mexico, Panama, Puerto Rico, South Africa
Triangle Pharmaceuticals

Unknown

A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

HIV Infections

United States, Puerto Rico, Canada, Argentina, Chile, Mexico
Centers for Disease Control and Prevention
Children's Research Triangle

Completed

Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)

Fetal Alcohol Syndrome | Alcohol-related Neurodevelopmental Disorder

United States
Abbott
Assign Data Management and Biostatistics GmbH

Completed

Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs (QUALITY)

Psoriasis Chronic

Austria
Abbott
Assign Data Management and Biostatistics GmbH

Completed

Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Premature Infants 33 - 35 wGA

Premature Infants

Austria
S.LAB (SOLOWAYS)
Center of New Medical Technologies; Triangel Scientific

Completed

Effectiveness and Safety of Semaglutide Combined With Dietary Fiber (Soloways) in Adults With Overweight or Obesity (ESSENCE)

Overweight and Obesity

Russian Federation
S.LAB (SOLOWAYS)
Center of New Medical Technologies; Triangel Scientific

Completed

Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms. (VITAGEN-H)

Hyperlipoproteinemias | Hyperhomocysteinemia

Russian Federation
Universidade Federal do Triangulo Mineiro

Unknown

Effect of Resistance Training Variable Manipulation in Postmenopausal Breast Cancer Survivors.

Postmenopause | Breast Cancer Survivors

Brazil
Universidade Federal do Triangulo Mineiro

Unknown

Fatigability and Physical Performance: Effects of Resistance Training Variables Manipulation

Aging

Brazil
HyGIeaCare, Inc.
Biostatistical Consulting, Inc.

Withdrawn

HyGIeaCare Procedure for Chronic Constipation

Constipation - Functional

United States
Universidade Federal do Triangulo Mineiro

Recruiting

Effects of Laying on of Hands in Fibromyalgia

Fibromyalgia

Brazil
Universidade Federal do Triangulo Mineiro

Recruiting

The Evaluation Complementary Spirit Therapy

Depression | Pain | Stress | Anxiety | Well-being

Brazil
Universidade Federal do Triangulo Mineiro

Completed

Study of Spirit Pass in Newborn and Patient (SSPNP)

Pain | Stress

Brazil
Universidade Federal do Triangulo Mineiro

Completed

Cachexia in Gynecological Cancer and the Preventive Role of Weight Training

Gynecologic Cancer | Physical Activity | Menopause | Breast Cancer Female
Universidade Federal do Triangulo Mineiro

Completed

Dual Task in Institutionalized Elderly

Aging
Universidade Federal do Triangulo Mineiro

Completed

Pilates and Muscle Strength Respiratory

Conditions

Brazil
GI Dynamics
Biostatistical Consulting, Inc.

Recruiting

EndoBarrier System Pivotal Trial(Rev E v2) (STEP-1)

Obesity | Diabetes type2

United States
Lislei Jorge Patrizzi

Completed

Strengthening in Functional Mobility of Active Elderly

Aged | Muscle Strength

Brazil
NHS Greater Glasgow and Clyde
Robertson Centre for Biostatistics

Recruiting

Study to Determine the Feasibility of Using an At-home Foot Temperature Monitoring Device (Thermidas)

Foot Ulcer, Diabetic

United Kingdom
S.LAB (SOLOWAYS)
Center of New Medical Technologies; Triangel Scientific

Completed

Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms (SOLIPARG)

LDL Hyperlipoproteinemia | Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia | Triglyceride Storage Type I or II Disease

Russian Federation
S.LAB (SOLOWAYS)
Center of New Medical Technologies; Triangel Scientific

Completed

Preventing Weight Regain Post-Semaglutide Treatment With Active Fiber Supplement (Soloways) (PWR-FAST)

Overweight and Obesity

Russian Federation
S.LAB (SOLOWAYS)
Center of New Medical Technologies; Triangel Scientific

Completed

Efficacy of Dietary Fiber Supplementation (Soloways) in Patients With Specific Genetic Polymorphisms (SOLFIBERGP)

Obesity

Russian Federation
AeskuLab Pathology Prague
Institute of Biostatistics and analyses, Ltd.

Completed

Algorithm for Cervix Carcinoma Screening in CZ Using the Detection of HPV DNA and CINtec Plus (LIBUSE)

Algorithm for Cervix Carcinoma Screening

Czechia
Alain Nordmann

Terminated

Smartphone App and CO Self-monitoring for Smoking Cessation (SMART-CO)

Smoking | HIV

Switzerland
Centre Leon Berard
The Biostatistics and Therapy Evaluation Unit

Completed

Protocole Advanced RadioTherapy ORL (ART-ORL)

Head and Neck Squamous Cell Carcinoma

France
Organon and Co
IQVIA Inc.; OSTAtistics

Terminated

Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive

Contraception

United States
Pfizer
Biostatistics, Preventive Medicinte Department, College of Medicine, Yonsei...

Completed

Rheumatoid Arthritis Satisfaction Outcome Research

Rheumatoid Arthritis

Korea, Republic of
Arbeitsgemeinschaft medikamentoese Tumortherapie
Amgen; Assign Data Management and Biostatistics GmbH

Active, not recruiting

Denosumab for High Risk SMM and SLiM CRAB Positive, Early Myeloma Patients (DEFENCE)

Multiple Myeloma

Austria, Germany, Israel
Themis Bioscience GmbH
Assign Data Management and Biostatistics GmbH; Optimapharm

Withdrawn

A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract

Gastrointestinal Cancer

Germany
Nova Southeastern University
Southeastern Orthopedics Sports Medicine and Shoulder Center; Triangle Volleyball...

Completed

Scapular Stabilization During Manual Horizontal Adduction Stretches and Its Effect on Increasing Posterior Shoulder Flexibility

Posterior Shoulder Tightness

United States
AbbVie (prior sponsor, Abbott)
Assign Data Management and Biostatistics GmbH

Completed

Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

Secondary Hyperparathyroidism | Chronic Kidney Disease Stage V | Cardiac Morbidity

Austria
Adriana Clemente Mendonça

Completed

Comparison of the Effects of Carboxytherapy and Radiofrequency on Skin Rejuvenation

Skin Aging | Skin Rejuvenation

Brazil
AIO-Studien-gGmbH
Novartis Pharmaceuticals; Assign Data Management and Biostatistics GmbH

Completed

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study (EVINEC)

Neuroendocrine Carcinoma, Grade 3 | Poorly Differentiated Malignant Neuroendocrine Carcinoma | Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 | Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma]... and other conditions

Germany

Clinical Trials Sponsored by Triangle Biostatistics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations